Vrijbloed, Jan Willem,Hettwer, Stefan,KUCSERA, Stefan
申请号：
DK16157895
公开号：
DK3050569T3
申请日:
2010.09.01
申请国别(地区):
DK
年份:
2019
代理人:
摘要：
Modified agrin fragment having in vivo activity, comprising at least the domains LG2 and LG3 of human agrin in covalently interlinked form and modified in such a way that the fragment cannot be cleaved by neurotrypsin for use as medicament.
